Long-Term Outcome of Paediatric Crohn's Disease Patients With Deep Ulcerations at Diagnosis

Monica S Ronconi1, Antoine Neuraz2, Elise Payen1

  • 1Service de Gastro-Entérologie et Nutrition Pédiatrique, Centre de Référence Des Maladies Rares Digestives (MARDI), Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Université Paris Cité, Paris, France.

Insights

Deep ulcerations in pediatric Crohn's disease (CD) patients predict more complications and relapses within the first year. However, this association diminishes over time due to proactive treatment strategies.

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Clinical Pediatrics

Background:

  • Deep ulcerations (DU) at diagnosis are linked to severe Crohn's disease (CD) phenotypes in adults.
  • Understanding early indicators of disease severity in pediatric CD is crucial for timely intervention.

Purpose of the Study:

  • To determine if DU at diagnosis predicts a more severe disease course in pediatric CD patients.
  • To investigate the long-term impact of DU on disease progression and complications in children.

Main Methods:

  • Retrospective analysis of 116 pediatric CD patients diagnosed between 2009 and 2017.
  • Comparison of disease course, complications, and treatment based on the presence or absence of DU at diagnosis via colonoscopy.
  • Data collection included clinical, laboratory, treatment, and complication information at diagnosis and 1, 3, and 5 years post-diagnosis.

Main Results:

  • 52 out of 116 pediatric patients had DU at diagnosis.
  • Patients with DU showed a significantly higher risk of abdominal abscesses (p=0.045) and relapses (p=0.013) within the first year.
  • No significant differences in disease course were observed between groups at 3 and 5 years.
  • Pediatric CD patients with DU received anti-TNF alpha therapy sooner after diagnosis.

Conclusions:

  • DU at diagnosis is associated with increased complications and relapses in the initial year of pediatric Crohn's disease.
  • Aggressive therapeutic management, including earlier anti-TNF alpha initiation, mitigates the long-term impact of DU.
  • DU serves as an important early marker for intensified monitoring and treatment in pediatric CD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
122
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
55
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
298
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
91
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
219
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
84